Organ Transplantation Immunosuppressive Drug Market Report

China Organ Transplantation Immunosuppressive Drug Industry Market Research Report 2023-2029

  • POSTDATE：Aug 23, 2023
  • PAGES：199
  • REPORT CODE：GMM1751453
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Organ transplant immunosuppressant drugs are the category of drugs which are administered to minimize the chances of organ rejection after transplantation. When a person undergoes any transplantation, the body recognizes the transplant as a foreign tissue and attacks it, resulting in rejection. These drugs dilute the immune system, hence reducing the reaction towards the transplant. The factors driving this market include the advancements made in tissue engineering and organ transplantations. These transplantations help in survival of many patients as well as enhance the quality of life. The lack of availability of organs and high cost of transplantation are the limitations for the growth of this market. The increase in use of tissue engineering for generation of implants provides growth opportunity to this market.

    This report elaborates on the current development of the Organ Transplantation Immunosuppressive Drug industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Bristol-Myers Squibb Company

    • GlaxoSmithKline plc

    • Genzyme Corporation（Sanofi SA）

    • FHoffmann-La Roche Ltd

    • Janssen Pharmaceuticals, Inc

    • Veloxis Pharmaceuticals A/S

    • Pfizer, Inc

    • AbbVie, Inc

    • Novartis Pharmaceuticals Corporation

    By Type:

    • mTOR Inhibitors

    • Antibodies

    • Steroids

    • Antiproliferative Agents

    • Calcineurin Inhibitors

    By Application:

    • Heart

    • Lungs

    • Kidney

    • Liver

    • Others (Intestinal and Multi-visceral Organs)

    • Bone Marrow

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Organ Transplantation Immunosuppressive Drug Market Overview 2018-2029

    • 1.1 China Organ Transplantation Immunosuppressive Drug Industry Development Overview

    • 1.2 China Organ Transplantation Immunosuppressive Drug Industry Development History

    • 1.3 China Organ Transplantation Immunosuppressive Drug Industry Market Size (2018-2029)

    • 1.4 China Organ Transplantation Immunosuppressive Drug Market Analysis by Type from Production Side

      • 1.4.1 China Organ Transplantation Immunosuppressive Drug Production Volume, Production Value and Growth Rate of mTOR Inhibitors (2018-2029)

      • 1.4.2 China Organ Transplantation Immunosuppressive Drug Production Volume, Production Value and Growth Rate of Antibodies (2018-2029)

      • 1.4.3 China Organ Transplantation Immunosuppressive Drug Production Volume, Production Value and Growth Rate of Steroids (2018-2029)

      • 1.4.4 China Organ Transplantation Immunosuppressive Drug Production Volume, Production Value and Growth Rate of Antiproliferative Agents (2018-2029)

      • 1.4.5 China Organ Transplantation Immunosuppressive Drug Production Volume, Production Value and Growth Rate of Calcineurin Inhibitors (2018-2029)

    • 1.5 China Organ Transplantation Immunosuppressive Drug Market Analysis by Application from Consumption End

      • 1.5.1 China Organ Transplantation Immunosuppressive Drug Sales Volume, Sales Value and Growth Rate of Heart (2018-2029)

      • 1.5.2 China Organ Transplantation Immunosuppressive Drug Sales Volume, Sales Value and Growth Rate of Lungs (2018-2029)

      • 1.5.3 China Organ Transplantation Immunosuppressive Drug Sales Volume, Sales Value and Growth Rate of Kidney (2018-2029)

      • 1.5.4 China Organ Transplantation Immunosuppressive Drug Sales Volume, Sales Value and Growth Rate of Liver (2018-2029)

      • 1.5.5 China Organ Transplantation Immunosuppressive Drug Sales Volume, Sales Value and Growth Rate of Others (Intestinal and Multi-visceral Organs) (2018-2029)

      • 1.5.6 China Organ Transplantation Immunosuppressive Drug Sales Volume, Sales Value and Growth Rate of Bone Marrow (2018-2029)

    • 1.6 China Organ Transplantation Immunosuppressive Drug Market Analysis by Region

      • 1.6.1 North China Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2018-2029

    Chapter 2 China Organ Transplantation Immunosuppressive Drug Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Organ Transplantation Immunosuppressive Drug Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Organ Transplantation Immunosuppressive Drug Market Status and Competition Analysis in 2023

      • 2.2.3 China Organ Transplantation Immunosuppressive Drug Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Organ Transplantation Immunosuppressive Drug Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Organ Transplantation Immunosuppressive Drug Industry Development

    Chapter 3 Organ Transplantation Immunosuppressive DrugIndustry Chain Analysis

    • 3.1 Organ Transplantation Immunosuppressive Drug Industry Chain

    • 3.2 Organ Transplantation Immunosuppressive Drug Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Organ Transplantation Immunosuppressive Drug Market

    • 3.3 Organ Transplantation Immunosuppressive Drug Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Organ Transplantation Immunosuppressive Drug Market

    Chapter 4 China Organ Transplantation Immunosuppressive Drug Market, by Type

    • 4.1 China Organ Transplantation Immunosuppressive Drug Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Organ Transplantation Immunosuppressive Drug Total Production Volume and Growth Rate from Production Side

    • 4.5 China Organ Transplantation Immunosuppressive Drug Production Volume and Growth Rate, by Type

      • 4.5.1 China Organ Transplantation Immunosuppressive Drug Production Volume and Growth Rate of mTOR Inhibitors

      • 4.5.2 China Organ Transplantation Immunosuppressive Drug Production Volume and Growth Rate of Antibodies

      • 4.5.3 China Organ Transplantation Immunosuppressive Drug Production Volume and Growth Rate of Steroids

      • 4.5.4 China Organ Transplantation Immunosuppressive Drug Production Volume and Growth Rate of Antiproliferative Agents

      • 4.5.5 China Organ Transplantation Immunosuppressive Drug Production Volume and Growth Rate of Calcineurin Inhibitors

    Chapter 5 China Organ Transplantation Immunosuppressive Drug Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Organ Transplantation Immunosuppressive Drug Total Market Size and Growth Rate from Consumption End

    • 5.5 China Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate, by Application

      • 5.5.1 China Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate of Heart

      • 5.5.2 China Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate of Lungs

      • 5.5.3 China Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate of Kidney

      • 5.5.4 China Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate of Liver

      • 5.5.5 China Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate of Others (Intestinal and Multi-visceral Organs)

      • 5.5.6 China Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate of Bone Marrow

    Chapter 6 China Organ Transplantation Immunosuppressive Drug Market, by Region

    • 6.1 China Organ Transplantation Immunosuppressive Drug Production Volume and Production Value, by Region

    • 6.2 China Organ Transplantation Immunosuppressive Drug Sales Volume and Sales Value, by Region

    Chapter 7 North China Organ Transplantation Immunosuppressive Drug Market Analysis

    • 7.1 North China Organ Transplantation Immunosuppressive Drug Market, by Type

    • 7.2 North China Organ Transplantation Immunosuppressive Drug Market, by Application

    Chapter 8 Central China Organ Transplantation Immunosuppressive Drug Market Analysis

    • 8.1 Central China Organ Transplantation Immunosuppressive Drug Market, by Type

    • 8.2 Central China Organ Transplantation Immunosuppressive Drug Market, by Application

    Chapter 9 South China Organ Transplantation Immunosuppressive Drug Market Analysis

    • 9.1 South China Organ Transplantation Immunosuppressive Drug Market, by Type

    • 9.2 South China Organ Transplantation Immunosuppressive Drug Market, by Application

    Chapter 10 East China Organ Transplantation Immunosuppressive Drug Market Analysis

    • 10.1 East China Organ Transplantation Immunosuppressive Drug Market, by Type

    • 10.2 East China Organ Transplantation Immunosuppressive Drug Market, by Application

    Chapter 11 Northeast China Organ Transplantation Immunosuppressive Drug Market Analysis

    • 11.1 Northeast China Organ Transplantation Immunosuppressive Drug Market, by Type

    • 11.2 Northeast China Organ Transplantation Immunosuppressive Drug Market, by Application

    Chapter 12 Southwest China Organ Transplantation Immunosuppressive Drug Market Analysis

    • 12.1 Southwest China Organ Transplantation Immunosuppressive Drug Market, by Type

    • 12.2 Southwest China Organ Transplantation Immunosuppressive Drug Market, by Application

    Chapter 13 Northwest China Organ Transplantation Immunosuppressive Drug Market Analysis

    • 13.1 Northwest China Organ Transplantation Immunosuppressive Drug Market, by Type

    • 13.2 Northwest China Organ Transplantation Immunosuppressive Drug Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Bristol-Myers Squibb Company

        • 14.1.1 Bristol-Myers Squibb Company Company Profile

        • 14.1.2 Bristol-Myers Squibb Company Organ Transplantation Immunosuppressive Drug Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 GlaxoSmithKline plc

        • 14.2.1 GlaxoSmithKline plc Company Profile

        • 14.2.2 GlaxoSmithKline plc Organ Transplantation Immunosuppressive Drug Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Genzyme Corporation（Sanofi SA）

        • 14.3.1 Genzyme Corporation（Sanofi SA） Company Profile

        • 14.3.2 Genzyme Corporation（Sanofi SA） Organ Transplantation Immunosuppressive Drug Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 FHoffmann-La Roche Ltd

        • 14.4.1 FHoffmann-La Roche Ltd Company Profile

        • 14.4.2 FHoffmann-La Roche Ltd Organ Transplantation Immunosuppressive Drug Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Janssen Pharmaceuticals, Inc

        • 14.5.1 Janssen Pharmaceuticals, Inc Company Profile

        • 14.5.2 Janssen Pharmaceuticals, Inc Organ Transplantation Immunosuppressive Drug Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Veloxis Pharmaceuticals A/S

        • 14.6.1 Veloxis Pharmaceuticals A/S Company Profile

        • 14.6.2 Veloxis Pharmaceuticals A/S Organ Transplantation Immunosuppressive Drug Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Pfizer, Inc

        • 14.7.1 Pfizer, Inc Company Profile

        • 14.7.2 Pfizer, Inc Organ Transplantation Immunosuppressive Drug Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 AbbVie, Inc

        • 14.8.1 AbbVie, Inc Company Profile

        • 14.8.2 AbbVie, Inc Organ Transplantation Immunosuppressive Drug Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Novartis Pharmaceuticals Corporation

        • 14.9.1 Novartis Pharmaceuticals Corporation Company Profile

        • 14.9.2 Novartis Pharmaceuticals Corporation Organ Transplantation Immunosuppressive Drug Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Organ Transplantation Immunosuppressive Drug Industry Research Conclusions

    • 15.2 Organ Transplantation Immunosuppressive Drug Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Organ Transplantation Immunosuppressive Drug Industry Market Size (2018-2029)

    • Figure China Organ Transplantation Immunosuppressive Drug Production Volume, Production Value and Growth Rate of mTOR Inhibitors (2018-2029)

    • Figure China Organ Transplantation Immunosuppressive Drug Production Volume, Production Value and Growth Rate of Antibodies (2018-2029)

    • Figure China Organ Transplantation Immunosuppressive Drug Production Volume, Production Value and Growth Rate of Steroids (2018-2029)

    • Figure China Organ Transplantation Immunosuppressive Drug Production Volume, Production Value and Growth Rate of Antiproliferative Agents (2018-2029)

    • Figure China Organ Transplantation Immunosuppressive Drug Production Volume, Production Value and Growth Rate of Calcineurin Inhibitors (2018-2029)

    • Figure China Organ Transplantation Immunosuppressive Drug Sales Volume, Sales Value and Growth Rate of Heart (2018-2029)

    • Figure China Organ Transplantation Immunosuppressive Drug Sales Volume, Sales Value and Growth Rate of Lungs (2018-2029)

    • Figure China Organ Transplantation Immunosuppressive Drug Sales Volume, Sales Value and Growth Rate of Kidney (2018-2029)

    • Figure China Organ Transplantation Immunosuppressive Drug Sales Volume, Sales Value and Growth Rate of Liver (2018-2029)

    • Figure China Organ Transplantation Immunosuppressive Drug Sales Volume, Sales Value and Growth Rate of Others (Intestinal and Multi-visceral Organs) (2018-2029)

    • Figure China Organ Transplantation Immunosuppressive Drug Sales Volume, Sales Value and Growth Rate of Bone Marrow (2018-2029)

    • Figure North China Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2018-2029

    • Figure Central China Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2018-2029

    • Figure South China Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2018-2029

    • Figure East China Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2018-2029

    • Figure Organ Transplantation Immunosuppressive Drug Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Organ Transplantation Immunosuppressive Drug Market Share by Type in 2018

    • Figure China Organ Transplantation Immunosuppressive Drug Market Share by Type in 2023

    • Figure China Organ Transplantation Immunosuppressive Drug Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Organ Transplantation Immunosuppressive Drug Production Volume and Growth Rate of mTOR Inhibitors (2018-2023)

    • Figure China Organ Transplantation Immunosuppressive Drug Production Volume and Growth Rate of Antibodies (2018-2023)

    • Figure China Organ Transplantation Immunosuppressive Drug Production Volume and Growth Rate of Steroids (2018-2023)

    • Figure China Organ Transplantation Immunosuppressive Drug Production Volume and Growth Rate of Antiproliferative Agents (2018-2023)

    • Figure China Organ Transplantation Immunosuppressive Drug Production Volume and Growth Rate of Calcineurin Inhibitors (2018-2023)

    • Figure China Organ Transplantation Immunosuppressive Drug Market Share by Application in 2018

    • Figure China Organ Transplantation Immunosuppressive Drug Market Share by Application in 2023

    • Figure China Organ Transplantation Immunosuppressive Drug Total Market Size and Growth Rate from Consumption End

    • Figure China Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate of Heart (2018-2023)

    • Figure China Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate of Lungs (2018-2023)

    • Figure China Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate of Kidney (2018-2023)

    • Figure China Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate of Liver (2018-2023)

    • Figure China Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate of Others (Intestinal and Multi-visceral Organs) (2018-2023)

    • Figure China Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate of Bone Marrow (2018-2023)

    • Table China Organ Transplantation Immunosuppressive Drug Production Volume by Region (2018-2023)

    • Table China Organ Transplantation Immunosuppressive Drug Production Volume Share by Region (2018-2023)

    • Figure China Organ Transplantation Immunosuppressive Drug Production Volume Share by Region (2018-2023)

    • Table China Organ Transplantation Immunosuppressive Drug Production Value by Region (2018-2023)

    • Table China Organ Transplantation Immunosuppressive Drug Production Value Share by Region (2018-2023)

    • Figure China Organ Transplantation Immunosuppressive Drug Production Value Share by Region (2018-2023)

    • Table China Organ Transplantation Immunosuppressive Drug Sales Volume by Region (2018-2023)

    • Table China Organ Transplantation Immunosuppressive Drug Sales Volume Share by Region (2018-2023)

    • Figure China Organ Transplantation Immunosuppressive Drug Sales Volume Share by Region (2018-2023)

    • Table China Organ Transplantation Immunosuppressive Drug Sales Value by Region (2018-2023)

    • Table China Organ Transplantation Immunosuppressive Drug Sales Value Share by Region (2018-2023)

    • Figure China Organ Transplantation Immunosuppressive Drug Sales Value Share by Region (2018-2023)

    • Table North China Organ Transplantation Immunosuppressive Drug Production Volume by Type (2018-2023)

    • Table North China Organ Transplantation Immunosuppressive Drug Production Volume Share by Type (2018-2023)

    • Figure North China Organ Transplantation Immunosuppressive Drug Production Volume Share by Type (2018-2023)

    • Table North China Organ Transplantation Immunosuppressive Drug Sales Volume by Application (2018-2023)

    • Table North China Organ Transplantation Immunosuppressive Drug Sales Volume Share by Application (2018-2023)

    • Figure North China Organ Transplantation Immunosuppressive Drug Sales Volume Share by Application (2018-2023)

    • Table Central China Organ Transplantation Immunosuppressive Drug Production Volume by Type (2018-2023)

    • Table Central China Organ Transplantation Immunosuppressive Drug Production Volume Share by Type (2018-2023)

    • Figure Central China Organ Transplantation Immunosuppressive Drug Production Volume Share by Type (2018-2023)

    • Table Central China Organ Transplantation Immunosuppressive Drug Sales Volume by Application (2018-2023)

    • Table Central China Organ Transplantation Immunosuppressive Drug Sales Volume Share by Application (2018-2023)

    • Figure Central China Organ Transplantation Immunosuppressive Drug Sales Volume Share by Application (2018-2023)

    • Table South China Organ Transplantation Immunosuppressive Drug Production Volume by Type (2018-2023)

    • Table South China Organ Transplantation Immunosuppressive Drug Production Volume Share by Type (2018-2023)

    • Figure South China Organ Transplantation Immunosuppressive Drug Production Volume Share by Type (2018-2023)

    • Table South China Organ Transplantation Immunosuppressive Drug Sales Volume by Application (2018-2023)

    • Table South China Organ Transplantation Immunosuppressive Drug Sales Volume Share by Application (2018-2023)

    • Figure South China Organ Transplantation Immunosuppressive Drug Sales Volume Share by Application (2018-2023)

    • Table East China Organ Transplantation Immunosuppressive Drug Production Volume by Type (2018-2023)

    • Table East China Organ Transplantation Immunosuppressive Drug Production Volume Share by Type (2018-2023)

    • Figure East China Organ Transplantation Immunosuppressive Drug Production Volume Share by Type (2018-2023)

    • Table East China Organ Transplantation Immunosuppressive Drug Sales Volume by Application (2018-2023)

    • Table East China Organ Transplantation Immunosuppressive Drug Sales Volume Share by Application (2018-2023)

    • Figure East China Organ Transplantation Immunosuppressive Drug Sales Volume Share by Application (2018-2023)

    • Table Northeast China Organ Transplantation Immunosuppressive Drug Production Volume by Type (2018-2023)

    • Table Northeast China Organ Transplantation Immunosuppressive Drug Production Volume Share by Type (2018-2023)

    • Figure Northeast China Organ Transplantation Immunosuppressive Drug Production Volume Share by Type (2018-2023)

    • Table Northeast China Organ Transplantation Immunosuppressive Drug Sales Volume by Application (2018-2023)

    • Table Northeast China Organ Transplantation Immunosuppressive Drug Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Organ Transplantation Immunosuppressive Drug Sales Volume Share by Application (2018-2023)

    • Table Southwest China Organ Transplantation Immunosuppressive Drug Production Volume by Type (2018-2023)

    • Table Southwest China Organ Transplantation Immunosuppressive Drug Production Volume Share by Type (2018-2023)

    • Figure Southwest China Organ Transplantation Immunosuppressive Drug Production Volume Share by Type (2018-2023)

    • Table Southwest China Organ Transplantation Immunosuppressive Drug Sales Volume by Application (2018-2023)

    • Table Southwest China Organ Transplantation Immunosuppressive Drug Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Organ Transplantation Immunosuppressive Drug Sales Volume Share by Application (2018-2023)

    • Table Northwest China Organ Transplantation Immunosuppressive Drug Production Volume by Type (2018-2023)

    • Table Northwest China Organ Transplantation Immunosuppressive Drug Production Volume Share by Type (2018-2023)

    • Figure Northwest China Organ Transplantation Immunosuppressive Drug Production Volume Share by Type (2018-2023)

    • Table Northwest China Organ Transplantation Immunosuppressive Drug Sales Volume by Application (2018-2023)

    • Table Northwest China Organ Transplantation Immunosuppressive Drug Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Organ Transplantation Immunosuppressive Drug Sales Volume Share by Application (2018-2023)

    • Table Bristol-Myers Squibb Company Company Profile

    • Table Bristol-Myers Squibb Company Organ Transplantation Immunosuppressive Drug Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline plc Company Profile

    • Table GlaxoSmithKline plc Organ Transplantation Immunosuppressive Drug Revenue, Price and Gross (2018-2023)

    • Table Genzyme Corporation（Sanofi SA） Company Profile

    • Table Genzyme Corporation（Sanofi SA） Organ Transplantation Immunosuppressive Drug Revenue, Price and Gross (2018-2023)

    • Table FHoffmann-La Roche Ltd Company Profile

    • Table FHoffmann-La Roche Ltd Organ Transplantation Immunosuppressive Drug Revenue, Price and Gross (2018-2023)

    • Table Janssen Pharmaceuticals, Inc Company Profile

    • Table Janssen Pharmaceuticals, Inc Organ Transplantation Immunosuppressive Drug Revenue, Price and Gross (2018-2023)

    • Table Veloxis Pharmaceuticals A/S Company Profile

    • Table Veloxis Pharmaceuticals A/S Organ Transplantation Immunosuppressive Drug Revenue, Price and Gross (2018-2023)

    • Table Pfizer, Inc Company Profile

    • Table Pfizer, Inc Organ Transplantation Immunosuppressive Drug Revenue, Price and Gross (2018-2023)

    • Table AbbVie, Inc Company Profile

    • Table AbbVie, Inc Organ Transplantation Immunosuppressive Drug Revenue, Price and Gross (2018-2023)

    • Table Novartis Pharmaceuticals Corporation Company Profile

    • Table Novartis Pharmaceuticals Corporation Organ Transplantation Immunosuppressive Drug Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US